Lucia Health Guidelines, founded with a mission to revolutionize atrial fibrillation management and stroke prevention, offers advanced clinical decision support tools. The company's core vision is to enhance patient outcomes through intelligent, data-driven solutions. Their primary product, the Lucia AFib app, assists healthcare providers in making informed decisions for managing atrial fibrillation and preventing strokes, targeting a market of medical professionals and institutions focused on cardiovascular health.
Notable achievements include the nomination of their ER2EP Pilot Study using the Lucia AFib app as one of the Top 5 Abstracts at the 2023 HRX AbstracX. This recognition underscores the impact and innovation of Lucia Health Guidelines in the field of cardiovascular care. The company collaborates with leading cardiologists and healthcare experts to continuously refine its offerings, contributing significantly to improved clinical practices and patient health outcomes.